Akura Medical
United States
- Los Gatos, California
- 04/10/2023
- Series B
- $35,000,000
Focused on providing effective and easy-to-use clot removal to efficiently treat venous thromboembolisms (VTE)
- Industry Medical Device
- Website https://www.akuramed.com/
- LinkedIn https://www.linkedin.com/company/akura-med/about/
Related People
Murali SrivathsaFounder
United States -
San Francisco Bay Area
Mission-driven, versatile Medical Devices leader who can introduce bold solutions and strategic plans which drive rapid business and operational growth, translate cutting-edge concepts into game-changing commercial offerings, and seize emerging opportunities through a balanced mix of strategic partnerships, financial planning, and business due diligence. The answer to my "Why?" is to make a transformative change in the lives of patients and those who treat them.
✓ Consistently delivers high growth/profitability through vital blend of product innovation and commercialization, go-to-market strategies, transformational approaches to Education & Training, and operational plans. Proven business and leadership record honed across multiple functions from management to strategy, M&A, to R&D.
✓ Credited with leading matrix organizations in the development of next-gen product lines at Abbott and Guidant (Boston Scientific CRM), accounting for $900+Mn in annual revenues.
✓ Expert relationship management skills and emotional intelligence to build high-performance internal cross-functional teams, as well as long-lasting external strategic partnerships.
✓ Experience with building funding strategies and leading fundraises.
✓ Enjoys the challenges of new initiatives- excels at being able to add value with a singular combination of scientific and business acumen.
✓ Broad experience in both domestic and international markets.
ZBD | $40,000,000 | (Jan 23, 2026)
Allocation Strategy | $2,164,392 | (Jan 23, 2026)
Asymmetric Security | $4,200,000 | (Jan 23, 2026)
Cubby | $63,000,000 | (Jan 23, 2026)
Cambio | $18,000,000 | (Jan 23, 2026)
Cork Protocol | $5,500,000 | (Jan 23, 2026)
Yuki | $6,000,000 | (Jan 23, 2026)
Mia Labs | $20,000,000 | (Jan 23, 2026)
Mendra | $82,000,000 | (Jan 23, 2026)
Artie Technologies | $12,000,000 | (Jan 23, 2026)
Antidote Legal | $5,000,000 | (Jan 23, 2026)
One to One Health | $12,000,000 | (Jan 22, 2026)